This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Takayuki Yoshimori: Innovator in Antibody Research
Introduction
Takayuki Yoshimori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on innovative methods for measuring antibody activities and preparing erythropoietin solutions.
Latest Patents
Yoshimori's latest patents include a method for measuring the bonding activity of antibodies that mimics antibody-dependent cell-mediated cytotoxic activity. This invention provides a simple method capable of evaluating the binding activities of an antibody to both an antigen and an Fc receptor. The method involves mixing the antibody with an antigen labeled with a fluorescent resonance energy transfer donor or acceptor, followed by measuring the fluorescence level of the mixture. Additionally, he has developed an erythropoietin solution preparation that contains a poloxamer and maintains a pH of 6.5 to 7.5. This invention also includes a method for quantifying proteins in trace amounts.
Career Highlights
Yoshimori is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on groundbreaking research in the field of biopharmaceuticals.
Collaborations
Throughout his career, Yoshimori has collaborated with notable colleagues, including Masashi Sakita and Hidefumi Mizushima. These collaborations have contributed to the advancement of research in antibody technologies.
Conclusion
Takayuki Yoshimori's innovative work in antibody research and his contributions to the pharmaceutical industry highlight his importance as an inventor. His patents reflect a commitment to advancing medical science and improving therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
